Drug Metab Dispos. 1900; 18:138-45. k Ambien (zolpidem) package insert. New York: Sanofi-Synthelabo; 2004 Mar. April D. Miller, Pharm.D., is Critical Care Specialty Resident and Chief Resident ...

2000 - The company's equal joint venture with Rottapharm of Italy called Earth Wind and Fire Pharmaceuticals (EWF) has signed an agreement with French company Sanofi-Synthelabo to market the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sanofi has added another string to its Pompe disease therapy bow, after getting FDA approval for Nexviazyme, its latest therapy for the rare, inherited disorder. The US regulator has approved ...

Sanofi has made an interesting choice for its new head of R&D, turning to Houman Ashrafian, who has deep expertise in the biopharma industry, but can also draw on his most recent role as managing ...

Please find enclosed communication for the attention of the shareholders of the Company for Apportionment of Cost of Acquisition of Equity Shares of Sanofi India Limited and Sanofi Consumer Healthcare ...

Objective and Design: This open, non-comparative, multicentre study was designed to evaluate zolpidem consumption and evolution of its use for the treatment of insomnia on an 'as-needed' basis ...

Sanofi India Ltd., incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 14,385.85 Crore) operating in Pharmaceuticals sector. Sanofi India Ltd. key Products/Revenue Segments ...